How the pilidium larva grows.

Evodevo

Oregon Institute of Marine Biology, PO Box 5389, Charleston, OR 97420, USA.

Published: May 2014

Background: For animal cells, ciliation and mitosis appear to be mutually exclusive. While uniciliated cells can resorb their cilium to undergo mitosis, multiciliated cells apparently can never divide again. Nevertheless, many multiciliated epithelia in animals must grow or undergo renewal. The larval epidermis in a number of marine invertebrate larvae, such as those of annelids, mollusks and nemerteans, consists wholly or in part of multiciliated epithelial cells, generally organized into a swimming and feeding apparatus. Many of these larvae must grow substantially to reach metamorphosis. Do individual epithelial cells simply expand to accommodate an increase in body size, or are there dividing cells amongst them? If some cells divide, where are they located?

Results: We show that the nemertean pilidium larva, which is almost entirely composed of multiciliated cells, retains pockets of proliferative cells in certain regions of the body. Most of these are found near the larval ciliated band in the recesses between the larval lobes and lappets, which we refer to as axils. Cells in the axils contribute both to the growing larval body and to the imaginal discs that form the juvenile worm inside the pilidium.

Conclusions: Our findings not only explain how the almost-entirely multiciliated pilidium can grow, but also demonstrate direct coupling of larval and juvenile growth in a maximally-indirect life history.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017827PMC
http://dx.doi.org/10.1186/2041-9139-5-13DOI Listing

Publication Analysis

Top Keywords

cells
10
pilidium larva
8
multiciliated cells
8
cells divide
8
epithelial cells
8
multiciliated
5
larval
5
larva grows
4
grows background
4
background animal
4

Similar Publications

Exploring the dual roles of sec-dependent effectors from Candidatus Liberibacter asiaticus in immunity of citrus plants.

Plant Cell Rep

January 2025

MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, Guangzhou Key Laboratory of Spectral Analysis and Functional Probes, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou, 510631, China.

The three SDEs of CLas were expressed in citrus leaves by AuNPs-PEI mediated transient expression system, and promoted the proliferation of CLas and inhibited citrus immunity. Huanglongbing (HLB) is the most severe bacterial disease of citrus caused by Candidatus Liberibacter asiaticus (CLas). CLas suppress host immune responses and promote infection by sec-dependent effectors (SDEs), thus insight into HLB pathogenesis is urgently needed to develop effective management strategies.

View Article and Find Full Text PDF

We build and study an individual based model of the telomere length's evolution in a population across multiple generations. This model is a continuous time typed branching process, where the type of an individual includes its gamete mean telomere length and its age. We study its Malthusian's behaviour and provide numerical simulations to understand the influence of biologically relevant parameters.

View Article and Find Full Text PDF

Background/aims: Human mesenchymal stromal cells (hMSC) are multipotent adult cells commonly used in regenerative medicine as advanced therapy medicinal products. The expansion of these cells in xeno-free supplements is highly encouraged by regulatory agencies due to safety concerns. However, the number of supplements with robust performance and consistency for hMSC expansion are limited.

View Article and Find Full Text PDF

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells.

Cytotherapy

January 2025

Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, Ontario, Canada; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada; Department of Medicine, Division of Hematology, University of Toronto, Toronto, Ontario, Canada. Electronic address:

The December 2024 US Food and Drug Administration (FDA) approval of Mesoblast's Ryoncil (remestemcel-L-rknd)-allogeneic bone marrow mesenchymal stromal cell (MSC(M)) therapy-in pediatric acute steroid-refractory graft-versus-host-disease finally ended a long-lasting drought on approved MSC clinical products in the United States. While other jurisdictions-including Europe, Japan, India, and South Korea-have marketed autologous or allogeneic MSC products, the United States has lagged in its approval. The sponsor's significant efforts and investments, working closely with the FDA addressing concerns regarding clinical efficacy and consistent MSC potency through an iterative process that spanned several years, was rewarded with this landmark approval.

View Article and Find Full Text PDF

Adaptive immune resistance in cancer describes the various mechanisms by which tumors adapt to evade anti-tumor immune responses. IFN-γ induction of programmed death-ligand 1 (PD-L1) was the first defined and validated adaptive immune resistance mechanism. The endoplasmic reticulum (ER) is central to adaptive immune resistance as immune modulatory secreted and integral membrane proteins are dependent on ER.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!